CervoMed Inc.
CRVO
$9.56
$0.131.38%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -22.61M | -18.67M | -16.29M | -11.95M | -5.04M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -49.80K | 91.60K | 200.50K | 410.80K | -2.99M |
| Change in Net Operating Assets | -653.00K | -422.80K | -440.70K | 518.00K | 397.70K |
| Cash from Operations | -23.31M | -19.00M | -16.53M | -11.02M | -7.63M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 17.05M | -23.26M | -28.66M | -37.97M | -40.57M |
| Cash from Investing | 17.05M | -23.26M | -28.66M | -37.97M | -40.57M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 4.59M | 46.41M | 46.41M | 46.41M | 47.22M |
| Repurchase of Common Stock | -13.30K | -13.30K | -13.30K | -13.30K | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -93.40K | 10.34M |
| Cash from Financing | 4.58M | 46.40M | 46.40M | 46.31M | 57.56M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.69M | 4.13M | 1.21M | -2.68M | 9.36M |